SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 138 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $67,000 | -94.3% | 52,004 | -94.4% | 0.00% | -100.0% |
Q4 2021 | $1,174,000 | +19.2% | 924,598 | +104.5% | 0.00% | 0.0% |
Q3 2021 | $985,000 | -74.1% | 452,048 | -55.4% | 0.00% | -50.0% |
Q2 2021 | $3,802,000 | +66.9% | 1,013,820 | +45.1% | 0.00% | +100.0% |
Q1 2021 | $2,278,000 | -12.1% | 698,720 | -8.1% | 0.00% | -50.0% |
Q4 2020 | $2,592,000 | -17.8% | 760,091 | -1.7% | 0.00% | 0.0% |
Q3 2020 | $3,155,000 | +57.5% | 773,242 | +30.5% | 0.00% | 0.0% |
Q2 2020 | $2,003,000 | +309.6% | 592,717 | +182.5% | 0.00% | – |
Q1 2020 | $489,000 | -15.1% | 209,845 | +32.7% | 0.00% | – |
Q4 2019 | $576,000 | -57.5% | 158,160 | -3.1% | 0.00% | -100.0% |
Q3 2019 | $1,354,000 | +7.6% | 163,284 | +11.8% | 0.00% | 0.0% |
Q2 2019 | $1,258,000 | -2.5% | 146,075 | +21.1% | 0.00% | 0.0% |
Q1 2019 | $1,290,000 | +26.0% | 120,645 | +3.1% | 0.00% | 0.0% |
Q4 2018 | $1,024,000 | -51.9% | 117,006 | -7.8% | 0.00% | -50.0% |
Q3 2018 | $2,131,000 | -26.6% | 126,870 | -8.4% | 0.00% | -33.3% |
Q2 2018 | $2,904,000 | +40.7% | 138,542 | +8.0% | 0.00% | +50.0% |
Q1 2018 | $2,064,000 | -28.2% | 128,264 | -15.4% | 0.00% | -33.3% |
Q4 2017 | $2,873,000 | +80.6% | 151,592 | +34.1% | 0.00% | +50.0% |
Q3 2017 | $1,591,000 | +105.6% | 113,049 | +8.8% | 0.00% | +100.0% |
Q2 2017 | $774,000 | -9.8% | 103,935 | -21.3% | 0.00% | 0.0% |
Q1 2017 | $858,000 | +70.9% | 132,064 | +16.6% | 0.00% | 0.0% |
Q4 2016 | $502,000 | -34.1% | 113,304 | -30.5% | 0.00% | 0.0% |
Q3 2016 | $762,000 | -29.6% | 163,135 | -1.0% | 0.00% | -50.0% |
Q2 2016 | $1,082,000 | -2.7% | 164,703 | -5.8% | 0.00% | 0.0% |
Q1 2016 | $1,112,000 | +33.2% | 174,823 | +26.2% | 0.00% | +100.0% |
Q4 2015 | $835,000 | +30.7% | 138,547 | +29.6% | 0.00% | 0.0% |
Q3 2015 | $639,000 | +3.6% | 106,868 | +18.4% | 0.00% | 0.0% |
Q2 2015 | $617,000 | +158.2% | 90,248 | +129.4% | 0.00% | – |
Q1 2015 | $239,000 | -39.8% | 39,348 | -31.3% | 0.00% | -100.0% |
Q4 2014 | $397,000 | -4.1% | 57,267 | +12.6% | 0.00% | 0.0% |
Q3 2014 | $414,000 | +4.3% | 50,866 | +4.2% | 0.00% | 0.0% |
Q2 2014 | $397,000 | +162.9% | 48,816 | +153.6% | 0.00% | – |
Q1 2014 | $151,000 | -5.6% | 19,248 | +6.8% | 0.00% | – |
Q4 2013 | $160,000 | 0.0% | 18,027 | -5.9% | 0.00% | – |
Q3 2013 | $160,000 | +20.3% | 19,150 | +7.0% | 0.00% | – |
Q2 2013 | $133,000 | – | 17,892 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |